Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

Donations can be made direct to the TRC page on this link – scroll down to the orange Donate to Travel Retail Consortium ...

Topline results were announced from a phase 3 trial evaluating simufilam, an oral small molecule that targets the filamin A protein, for the treatment of mild to moderate Alzheimer disease (AD).

In the first arrangement of its kind, Eli Lilly to connect patients through telemedicine to providers of Alzheimer’s drugs.

Researchers at Boise State University are developing a virtual reality headset that monitors how well users detect certain ...

Discover Acumen Pharmaceuticals' progress on Alzheimer's treatment sabirnetug, Phase 2 trial updates, biomarker advancements, and financial strategies.

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 ...

Witnesses warned canceling projects in midstream could waste years of research data and drive away a generation of young ...

New research reveals that Type 2 diabetes may impair the brain’s reward and memory processing in ways that mirror early Alzheimer’s disease.

The results suggest that IGC-AD1 may decrease the frequency and severity of sleep disturbances and night time behaviours.